Target intelligence / Profile preview

Local bleeding site

Molecular classification
Other
01

Overview

A local bleeding site is a physiological location where vascular integrity has been compromised, leading to hemorrhage (StatPearls, NBK507702). While not a molecular target in the traditional sense, it serves as the site of action for various topical hemostatic agents used in surgery and trauma management. These agents interact with the physiological environment of the wound to promote clot formation through mechanical, hygroscopic, or enzymatic mechanisms. For instance, active hemostats like thrombin directly catalyze the conversion of fibrinogen to fibrin at the site, while passive agents like collagen or cellulose provide a matrix for platelet aggregation (Journal of Clinical Medicine, PMC8231146). Effective management of a local bleeding site is critical for preventing excessive blood loss and ensuring patient stability during invasive procedures. Understanding the local bleeding site is essential for the development of advanced biomaterials and sealants designed to achieve rapid hemostasis in trauma and elective surgery (PubMed, 31145144). The site serves as a focal point for the interaction between exogenous hemostatic materials and the patient's endogenous clotting mechanisms. Complications at the site can include re-bleeding, infection, or excessive inflammatory responses to foreign materials.

Other names
Hemorrhage siteSurgical bleeding siteWound bedBleeding surface
02

Mechanism of action

Topical hemostatic agents applied to the local bleeding site function through mechanical occlusion, acceleration of the coagulation cascade via enzymatic activity (e.g., thrombin), or by providing a scaffold for platelet adhesion and aggregation (StatPearls, NBK507702; Journal of Clinical Medicine, PMC8231146).

03

Biological functions

HemostasisBlood coagulationWound healing
04

Disease associations

HemorrhageTraumaSurgical bleedingCoagulopathy
05

Safety considerations

Systemic thromboembolismHypersensitivity reactionsTissue necrosisInfection riskAdhesion formation
06

Interacting drugs

Thrombin

5 more in the full profile.

07

Biomarkers

Time to hemostasisEstimated blood lossHemoglobin levelsVisual assessment of hemostasis

Beyond the preview

Go deeper on Local bleeding site.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Local bleeding site.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call